SCHEMBL18525478

SCHEMBL18525478

OB(O)c1ccc2c(c1)c1ccccc1n2-c1ccc(-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
ATM Q13315 1/20 0.52
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
PTPN1 P18031 2/20 0.37
HDAC4 P56524 1/20 0.36
MGLL Q99685 2/20 0.35
POLB P06746 1/20 0.35
LMNA P02545 2/20 0.35
ENPP2 Q13822 3/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34
CA14 Q9ULX7 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
GFER P55789 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17885353 0.98 KDM4E (0.50) KDM4EL3MBTL1ATMCA1CA2
SCHEMBL29943786 0.95 KDM4E (0.60) KDM4EL3MBTL1ATMCA1CA2
SCHEMBL29407532 0.95 KDM4E (0.60) KDM4EL3MBTL1ATMCA1CA2
SCHEMBL260470 0.95 KDM4E (0.60) KDM4EL3MBTL1ATMCA1CA2
SCHEMBL15762939 0.94 KDM4E (0.55) KDM4EL3MBTL1ATMCA1CA2
SCHEMBL18526037 0.94 KDM4E (0.55) KDM4EL3MBTL1ATMCA1CA2
SCHEMBL355186 0.92 KDM4E (0.44) KDM4EL3MBTL1ATMCA1CA2
SCHEMBL29975845 0.92 MGLL (0.49) KDM4EL3MBTL1ATMCA1CA2
SCHEMBL31050121 0.92 KDM4E (0.44) KDM4EL3MBTL1ATMCA1CA2
SCHEMBL30296694 0.92 KDM4E (0.44) KDM4EL3MBTL1ATMCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10934292-B2 Hexamethylindanes MERCK PATENT GMBH (DE) 2021-03-02 US disclosed
EP-3334708-B1 HEXAMETHYLINDANES MERCK PATENT GMBH (DE) 2020-08-19 EP disclosed
US-20200140440-A1 HEXAMETHYLINDANES MERCK PATENT GMBH (DE) 2020-05-07 US disclosed
US-20180141957-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-24 US disclosed
WO-2017025166-A1 HEXAMETHYLINDANES MERCK PATENT GMBH (DE) 2017-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934292-B2 Hexamethylindanes ALKBH5, ALKBH2, METTL3 KDM4E 431/4885L3MBTL1 997/4885ATM 4525/4885
US-20180141957-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 KDM4E 1121/4885L3MBTL1 561/4885ATM 4361/4885
US-20200140440-A1 HEXAMETHYLINDANES ALKBH5, ALKBH2, METTL3 KDM4E 431/4885L3MBTL1 997/4885ATM 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.